View of Estimation of risk of nephrogenic systemic fibrosis inpatients of stage 3-5 chronic kidney disease undergoing magnetic resonance imaging with injectable gadobutrol.

Return to Article Details Estimation of risk of nephrogenic systemic fibrosis inpatients of stage 3-5 chronic kidney disease undergoing magnetic resonance imaging with injectable gadobutrol. Download Download PDF